Field & Main Bank’s Bristol-Myers Squibb BMY Stock Holding History

Field & Main Bank’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$579K	Buy	9,546 +640	+7%	+$37.3K	0.17%	91
2025 Q4	$480K	Sell	8,906 -150	-2%	-$7.22K	0.14%	98
2025 Q3	$408K	Sell	9,056 -11,035	-55%	-$515K	0.12%	108
2025 Q2	$930K	Sell	20,091 -500	-2%	-$24.5K	0.3%	73
2025 Q1	$1.26M	Buy	20,591 +7,985	+63%	+$465K	0.44%	62
2024 Q4	$713K	Hold	12,606	–	–	0.25%	81
2024 Q3	$652K	Sell	12,606 -1,050	-8%	-$49.3K	0.23%	81
2024 Q2	$567K	Sell	13,656 -550	-4%	-$24.6K	0.21%	88
2024 Q1	$770K	Sell	14,206 -476	-3%	-$24.2K	0.3%	77
2023 Q4	$753K	Sell	14,682 -1,045	-7%	-$54.9K	0.32%	74
2023 Q3	$913K	Buy	15,727 +4,025	+34%	+$247K	0.43%	63
2023 Q2	$748K	Sell	11,702 -50	-0.4%	-$3.35K	0.42%	68
2023 Q1	$815K	Sell	11,752 -140	-1%	-$9.87K	0.49%	63
2022 Q4	$856K	Sell	11,892 -50	-0.4%	-$3.77K	0.55%	59
2022 Q3	$849K	Sell	11,942 -221	-2%	-$16K	0.57%	54
2022 Q2	$937K	Buy	12,163 +2,496	+26%	+$190K	0.6%	50
2022 Q1	$706K	Sell	9,667 -155	-2%	-$10.4K	0.43%	69
2021 Q4	$612K	Sell	9,822 -1,150	-10%	-$67.5K	0.35%	77
2021 Q3	$649K	Sell	10,972 -120	-1%	-$7.9K	0.43%	71
2021 Q2	$741K	Sell	11,092 -49	-0.4%	-$3.19K	0.47%	68
2021 Q1	$703K	Buy	11,141 +100	+0.9%	+$6.22K	0.5%	61
2020 Q4	$685K	Sell	11,041 -1,060	-9%	-$65.2K	0.51%	60
2020 Q3	$730K	Buy	12,101 +345	+3%	+$20.8K	0.56%	57
2020 Q2	$691K	Buy	+11,756	New	+$703K	0.59%	54
2019 Q4	$677K	Buy	10,551 +1,445	+16%	+$82.8K	0.56%	57
2019 Q3	$462K	Sell	9,106 -1,229	-12%	-$57.8K	0.42%	70
2019 Q2	$469K	Sell	10,335 -1,175	-10%	-$54.7K	0.43%	69
2019 Q1	$549K	Buy	+11,510	New	+$573K	0.52%	63
2018 Q3	$932K	Sell	15,015 -150	-1%	-$8.9K	0.83%	41
2018 Q2	$891K	Buy	15,165 +980	+7%	+$52.9K	0.81%	42
2018 Q1	$897K	Sell	14,185 -300	-2%	-$19.3K	0.88%	36
2017 Q4	$887K	Buy	+14,485	New	+$906K	0.85%	36
2015 Q2	$513K	Hold	7,706	–	–	0.49%	74
2015 Q1	$497K	Hold	7,706	–	–	0.46%	76
2014 Q4	$455K	Hold	7,706	–	–	0.43%	78
2014 Q3	$394K	Sell	7,706 -50	-0.6%	-$2.5K	0.37%	87
2014 Q2	$376K	Hold	7,756	–	–	0.35%	83
2014 Q1	$403K	Hold	7,756	–	–	0.39%	82
2013 Q4	$412K	Buy	+7,756	New	+$395K	0.4%	82

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Field & Main Bank's BMY Position: Q1 2026 in Review

Field & Main Bank increased its Bristol-Myers Squibb (BMY) stake by 7.2% in Q1 2026, buying an estimated $37.3K and bringing the position to 9,546 shares worth $579K. The position accounts for 0.17% of the portfolio, ranked #91.

Field & Main Bank first reported a position in BMY in Q4 2013 and has held it in 39 quarters since. The position peaked at $1.26M in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Field & Main Bank held 9,546 shares of Bristol-Myers Squibb worth $579K as of Q1 2026.
Field & Main Bank bought 640 Bristol-Myers Squibb shares in Q1 2026, an estimated $37.3K.
Bristol-Myers Squibb made up 0.17% of Field & Main Bank's portfolio in Q1 2026, its #91 holding.
Field & Main Bank first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 39 quarters since.
Field & Main Bank's Bristol-Myers Squibb position peaked at $1.26M in Q1 2025.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Field & Main Bank's 13F filing for Q1 2026, filed 10 Apr 2026.